Cargando…

P1361: TREATMENT OF SEVERE STEROID-REFRACTORY ACUTE GVHD WITH MESENCHYMAL STROMAL CELLS: RESULTS OF THE PHASE III RANDOMIZED DOUBLE-BLIND MULTI-CENTER HOVON-113 TRIAL

Detalles Bibliográficos
Autores principales:	Oosten, L., van Pel, M., van der Holt, B., Bach, E., Cross, M., Roelofs, H., Meij, P., Wieles, B., Zwaginga, J. J., Lankester, A., Veelken, H., Platzbecker, U., Sanchez-Guijo, F., Algeri, M., Locatelli, F., Devos, T., Cornelissen, J., Niederwieser, D., Fibbe, W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430838/ http://dx.doi.org/10.1097/01.HS9.0000848304.76865.3a

Ejemplares similares

Anxiolytic Effects of the MCH1R Antagonist TPI 1361-17
por: Lee, Cheol, et al.
Publicado: (2010)

Clofarabine added to intensive treatment in adult patients with newly diagnosed ALL: the HOVON-100 trial
por: Rijneveld, Anita W., et al.
Publicado: (2022)

Dy(8)SnS(13.61)O(0.39) from single-crystal data
por: Daszkiewicz, M., et al.
Publicado: (2007)

Posttransplant cyclophosphamide for prevention of graft-versus-host disease: results of the prospective randomized HOVON-96 trial
por: Broers, Annoek E. C., et al.
Publicado: (2022)

A unique immune signature in blood separates therapy-refractory from therapy-responsive acute graft-versus-host disease
por: van Halteren, Astrid G. S., et al.
Publicado: (2023)

113 Etüden für Violoncello = 113 studies for violoncello = 113 gyakorlat gordonkára /
por: Dotzauer, J. J. F. (Justus Johann Friedrich), 1783-1860
Publicado: (1991)

The added value of multi‐state modelling in a randomized controlled trial: The HOVON 102 study re‐analyzed
por: Bakunina, Katerina, et al.
Publicado: (2021)

Does ureteral stenting matter for stone size? A retrospectıve analyses of 1361 extracorporeal shock wave lithotripsy patients
por: Ozkan, Burak, et al.
Publicado: (2015)

1361. Variation in Perioperative Antibiotic Use for Children Undergoing Congenital Heart Disease Surgery in U.S. Academically Affiliated Centers
por: Cooch, Peter B, et al.
Publicado: (2020)

Preparing for cell culture scale-out: establishing parity of bioreactor- and flask-expanded mesenchymal stromal cell cultures
por: Das, Ruud, et al.
Publicado: (2019)

Gut-grabbing T cells trigger GVHD
por: Van Epps, Heather L.
Publicado: (2005)

S249: SELECTIVE JAK2/IRAK1/ACVR1 INHIBITOR PACRITINIB BEFORE REDUCED-INTENSITY CONDITIONING ALLOGENEIC STEM CELL TRANSPLANTATION IN MYELOFIBROSIS: FINAL ANALYSIS OF THE PHASE II HOVON-134 TRIAL
por: Van Dijck, Ruben, et al.
Publicado: (2023)

Single mission workload and influencing factors in German prehospital emergency medicine - a nationwide prospective survey of 1361emergency missions
por: Prottengeier, Johannes, et al.
Publicado: (2019)

P1361: SLEEPING BEAUTY PLATFORM FOR ENGINEERING CAR-CIK CELLS TOWARD A MULTI-TARGETING STRATEGY IN B-ALL
por: Moretti, Alex, et al.
Publicado: (2023)

113 Violoncello-Etüden; ausgewählt progressiv
por: Dotzauer, J. J. F. (Justus Johann Friedrich), 1783-1860

P1176: RITUXIMAB IN PRIMARY CNS LYMPHOMA – LONG TERM FOLLOW-UP OF THE PHASE III HOVON 105/ALLG NHL 24 STUDY
por: Doorduijn, J., et al.
Publicado: (2022)

Background 113
por: CERN. Geneva. Intersecting Storage Ring Division
Publicado: (1971)

Survival Improvement over Time of 960 s-AML Patients Included in 13 EORTC-GIMEMA-HOVON Trials
por: Ramadan, Safaa M., et al.
Publicado: (2020)

Prospective validation of the prognostic relevance of CD34(+)CD38(–) AML stem cell frequency in the HOVON-SAKK132 trial
por: Ngai, Lok Lam, et al.
Publicado: (2023)

1361. Pharmacokinetics and Safety of Ridinilazole (RDZ), a Potential New Therapy for Clostridium difficile Infection (CDI): From Animal Models to Patients
por: Duperchy, Esther, et al.
Publicado: (2018)

Correction: Effect of AlF(3) on the Density and Elastic Properties of Zinc Tellurite Glass Systems. Materials 2012, 5, 1361-1372.
por: Sidek, Haji Abdul Aziz, et al.
Publicado: (2012)

1361. Knowledge, Attitude, and Practices on Drug-Resistant Tuberculosis Infection Control Among Healthcare Workers in Nepal: A Cross-Sectional Study
por: Kumar. Shrestha, Sailesh, et al.
Publicado: (2019)

Minimal residual disease assessment by multiparameter flow cytometry in transplant-eligible myeloma in the EMN02/HOVON 95 MM trial
por: Oliva, Stefania, et al.
Publicado: (2021)

Posttransplant cyclophosphamide vs tacrolimus–based GVHD prophylaxis: lower incidence of relapse and chronic GVHD
por: Maurer, Katie, et al.
Publicado: (2023)

The feasibility and efficacy of subcutaneous plerixafor for mobilization of peripheral blood stem cells in allogeneic HLA–identical sibling donors: results of the HOVON‐107 study
por: de Greef, Georgine E., et al.
Publicado: (2018)

CD4 Donor Lymphocyte Infusion Can Cause Conversion of Chimerism Without GVHD by Inducing Immune Responses Targeting Minor Histocompatibility Antigens in HLA Class II
por: van Balen, Peter, et al.
Publicado: (2018)

Chronic GVHD after steroid-sensitive, -dependent, and -refractory acute GVHD: incidence and clinical outcomes
por: Herzog, Shannon, et al.
Publicado: (2023)

GVHD Prophylaxis 2020
por: Gooptu, Mahasweta, et al.
Publicado: (2021)

1361. The association between antibody responses and prolonged viable SARS-CoV-2 shedding in immunocompromised patients: a prospective cohort study
por: Lim, So Yun, et al.
Publicado: (2023)

Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD
por: Hildebrandt, G C, et al.
Publicado: (2011)

Cytokine‐induced hematopoietic stem and progenitor cell mobilization: unraveling interactions between stem cells and their niche
por: de Kruijf, Evert‐Jan F.M., et al.
Publicado: (2019)

Nonrelapse mortality among patients diagnosed with chronic GVHD: an updated analysis from the Chronic GVHD Consortium
por: DeFilipp, Zachariah, et al.
Publicado: (2021)

Inflammasome effects in GvHD
por: Koehn, Brent H., et al.
Publicado: (2015)

Targeting Cytokines in GVHD Therapy
por: Kumar, Sandeep, et al.
Publicado: (2017)

Editorial: Interferons and GvHD
por: Kim, Boram, et al.
Publicado: (2022)

Regulatory T Cells in GVHD Therapy
por: Guo, Wen-wen, et al.
Publicado: (2021)

Milestones in acute GVHD pathophysiology
por: Socie, Gerard, et al.
Publicado: (2022)

Defect and diffusion forum vols 113-114
por: Fisher, David J
Publicado: (1998)

Utility of eGVHD App for bedside GVHD assessment in a high-volume BMT center
por: Chhabra, Prashant, et al.
Publicado: (2023)

113rd LHCC Meeting
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_3tlq59c7u8htcsac6gd649tt6o